-
1
-
-
79956216585
-
An update on cancer- and chemotherapy-related cognitive dysfunction: Current status
-
Janelsins MC, Kohli S, Mohile SG et al (2011) An update on cancer- and chemotherapy-related cognitive dysfunction: current status. Semin Oncol 38:431-438
-
(2011)
Semin Oncol
, vol.38
, pp. 431-438
-
-
Janelsins, M.C.1
Kohli, S.2
Mohile, S.G.3
-
2
-
-
79959558529
-
International cognition and cancer task force recommendations to harmonise studies of cognitive function in patients with cancer
-
Wefel JS, Vardy J, Ahles T, Schagen SB (2011) International cognition and cancer task force recommendations to harmonise studies of cognitive function in patients with cancer. Lancet Oncol 12:703-708
-
(2011)
Lancet Oncol
, vol.12
, pp. 703-708
-
-
Wefel, J.S.1
Vardy, J.2
Ahles, T.3
Schagen, S.B.4
-
3
-
-
77952217466
-
Effects on the visual system might contribute to some of the cognitive deficits of cancer chemotherapy- induced 'chemo-fog'
-
Raffa RB, Tallarida RJ (2010) Effects on the visual system might contribute to some of the cognitive deficits of cancer chemotherapy- induced 'chemo-fog'. J Clin Pharm Ther 35:249-255
-
(2010)
J Clin Pharm Ther
, vol.35
, pp. 249-255
-
-
Raffa, R.B.1
Tallarida, R.J.2
-
4
-
-
33846991965
-
CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and vivo
-
Dietrich J, Han R, Yang Y et al (2006) CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and vivo. J Biol 5:1-23
-
(2006)
J Biol
, vol.5
, pp. 1-23
-
-
Dietrich, J.1
Han, R.2
Yang, Y.3
-
5
-
-
58749089099
-
Clinical patterns and biological correlates of cognitive dysfunction associated with cancer therapy
-
Dietrich J, Monje M, Wefel J et al (2008) Clinical patterns and biological correlates of cognitive dysfunction associated with cancer therapy. Oncologist 13:1285-1295
-
(2008)
Oncologist
, vol.13
, pp. 1285-1295
-
-
Dietrich, J.1
Monje, M.2
Wefel, J.3
-
6
-
-
0345107251
-
Mechanisms of chemotherapy-induced cognitive disorders: Neuropsychological, pathophysiological, and neuroimaging perspectives
-
Saykin AJ, Ahles TA, McDonald BC (2003) Mechanisms of chemotherapy-induced cognitive disorders: neuropsychological, pathophysiological, and neuroimaging perspectives. Semin Clin Neuropsychiatry 8:201-216 (Pubitemid 37474731)
-
(2003)
Seminars in Clinical Neuropsychiatry
, vol.8
, Issue.4
, pp. 201-216
-
-
Saykin, A.J.1
Ahles, T.A.2
McDonald, B.C.3
-
7
-
-
78650923263
-
Evidence for acute neurotoxicity after chemotherapy
-
Petzold A, Mondria T, Kuhle J et al (2010) Evidence for acute neurotoxicity after chemotherapy. Ann Neurol 68:806-815
-
(2010)
Ann Neurol
, vol.68
, pp. 806-815
-
-
Petzold, A.1
Mondria, T.2
Kuhle, J.3
-
8
-
-
77956646449
-
The impact of chemo brain on the patient with a high-grade glioma
-
Lucas MR (2010) The impact of chemo brain on the patient with a high-grade glioma. Adv Exp Med Biol 678:21-25
-
(2010)
Adv Exp Med Biol
, vol.678
, pp. 21-25
-
-
Lucas, M.R.1
-
9
-
-
1842588763
-
Prediction of neurocognitive outcome in adult brain tumor patients
-
DOI 10.1023/B:NEON.0000021900.29176.58
-
Kaleita TA, Wellisch DK, Cloughesy TF et al (2004) Prediction of neurocognitive outcome in adult brain tumor patients. J Neurooncol 67:245-253 (Pubitemid 38418276)
-
(2004)
Journal of Neuro-Oncology
, vol.67
, Issue.1-2
, pp. 245-253
-
-
Kaleita, T.A.1
Wellisch, D.K.2
Cloughesy, T.F.3
Ford, J.M.4
Freeman, D.5
Belin, T.R.6
Goldman, J.7
-
10
-
-
77954947310
-
Neurocognitive function in brain tumors
-
Correa DD (2010) Neurocognitive function in brain tumors. Curr Neurol Neurosci Rep 10:232-239
-
(2010)
Curr Neurol Neurosci Rep
, vol.10
, pp. 232-239
-
-
Correa, D.D.1
-
11
-
-
70349319721
-
Central nervous system effects of natural and synthetic glucocorticoids
-
Fietta P, Fietta P, Delsante G (2009) Central nervous system effects of natural and synthetic glucocorticoids. Psychiatry Clin Neurosci 63(5):613-622
-
(2009)
Psychiatry Clin Neurosci
, vol.63
, Issue.5
, pp. 613-622
-
-
Fietta, P.1
Fietta, P.2
Delsante, G.3
-
12
-
-
0030001481
-
Neuropsychiatric disorders in cancer patients
-
Baile WF (1996) Neuropsychiatric disorders in cancer patients. Curr Opin Oncol 8(3):182-187 (Pubitemid 26200845)
-
(1996)
Current Opinion in Oncology
, vol.8
, Issue.3
, pp. 182-187
-
-
Baile, W.F.1
-
13
-
-
11344272898
-
Complications of radiation therapy on the brain and spinal cord
-
DOI 10.1055/s-2004-861535
-
Béhin A, Delattre JY (2004) Complications of radiation therapy on the brain and spinal cord. Semin Neurol 24(4):405-417 (Pubitemid 40076117)
-
(2004)
Seminars in Neurology
, vol.24
, Issue.4
, pp. 405-417
-
-
Behin, A.1
Delattre, J.-Y.2
-
14
-
-
34547840273
-
Cognitive functions in primary central nervous system lymphoma: Literature review and assessment guidelines
-
DOI 10.1093/annonc/mdl464
-
Correa DD, Maron L, Harder H et al (2007) Cognitive functions in primary central nervous system lymphoma: literature review and assessment guidelines. Ann Oncol 18:1145-1151 (Pubitemid 47244358)
-
(2007)
Annals of Oncology
, vol.18
, Issue.7
, pp. 1145-1151
-
-
Correa, D.D.1
Maron, L.2
Harder, H.3
Klein, M.4
Armstrong, C.L.5
Calabrese, P.6
Bromberg, J.E.C.7
Abrey, L.E.8
Batchelor, T.T.9
Schiff, D.10
-
15
-
-
0031693338
-
Phase II trial of chemotherapy alone for primary CNS and intraocular lymphoma
-
Sandor V, Stark-Vancs V, Pearson D et al (1998) Phase II trial of chemotherapy alone for primary CNS and intraocular lymphoma. J Clin Oncol 16:3000-3006 (Pubitemid 28417419)
-
(1998)
Journal of Clinical Oncology
, vol.16
, Issue.9
, pp. 3000-3006
-
-
Sandor, V.1
Stark-Vancs, V.2
Pearson, D.3
Nussenblat, R.4
Whitcup, S.M.5
Brouwers, P.6
Patronas, N.7
Heiss, J.8
Jaffe, E.9
DeSmet, M.10
Kohler, D.11
Simon, R.12
Wittes, R.13
-
16
-
-
33644497225
-
Cognitive functions in primary central nervous system lymphoma patients treated with chemotherapy and stem cell transplantation: Preliminary findings
-
Correa DD, Anderson ND, Glass A et al (2003) Cognitive functions in primary central nervous system lymphoma patients treated with chemotherapy and stem cell transplantation: preliminary findings. Clin Adv Hematol Oncol 1:490
-
(2003)
Clin Adv Hematol Oncol
, vol.1
, pp. 490
-
-
Correa, D.D.1
Anderson, N.D.2
Glass, A.3
-
17
-
-
0345700862
-
Cognitive performance and magnetic resonance imaging findings after high-dose systemic and intraventricular chemotherapy for primary central nervous system lymphoma
-
DOI 10.1001/archneur.60.4.563
-
Fliessbach K, Urbach H, Helmstaedter C et al (2003) Cognitive performance and magnetic resonance imaging findings after highdose systemic and intraventricular chemotherapy for primary central nervous system lymphoma. Arch Neurol 60:563-568 (Pubitemid 36427970)
-
(2003)
Archives of Neurology
, vol.60
, Issue.4
, pp. 563-568
-
-
Fliessbach, K.1
Urbach, H.2
Helmstaedter, C.3
Pels, H.4
Glasmacher, A.5
Kraus, J.A.6
Klockgether, T.7
Schmidt-Wolf, I.8
Schlegel, U.9
-
18
-
-
20144387340
-
Neuropsychological outcome after chemotherapy for primary CNS lymphoma: A prospective study
-
Fliessbach K, Helmstaedter C, Urbach H et al (2005) Neuropsychological outcome after chemotherapy for primary CNS lymphoma: a prospective study. Neurology 64:1184-1188
-
(2005)
Neurology
, vol.64
, pp. 1184-1188
-
-
Fliessbach, K.1
Helmstaedter, C.2
Urbach, H.3
-
19
-
-
1042308841
-
Primary central nervous system lymphoma: Results of a pilot and phase II study of systemic and intraventricular chemotherapy with deferred radiotherapy
-
DOI 10.1200/JCO.2003.04.056
-
Pels H, Schmidt-Wolf IGH, Glasmacher A et al (2003) Primary central nervous system lymphoma: results of a pilot study and phase II study of systemic and intraventricular chemotherapy with deferred radiotherapy. J Clin Oncol 21:4489-4495 (Pubitemid 46594018)
-
(2003)
Journal of Clinical Oncology
, vol.21
, Issue.24
, pp. 4489-4495
-
-
Pels, H.1
Schmidt-Wolf, I.G.H.2
Glasmacher, A.3
Schulz, H.4
Engert, A.5
Diehl, V.6
Zellner, A.7
Schackert, G.8
Reichmann, H.9
Kroschinsky, F.10
Vogt-Schaden, M.11
Egerer, G.12
Bode, U.13
Schaller, C.14
Deckert, M.15
Fimmers, R.16
Helmstaedter, C.17
Atasoy, A.18
Klockgether, T.19
Schlegel, U.20
more..
-
20
-
-
0034962791
-
Combined systemic and intraventricular chemotherapy in primary CNS lymphoma: A pilot study
-
Schlegel U, Pels H, Glasmacher A et al (2001) Combined systemic and intraventricular chemotherapy in primary CNS lymphoma: a pilot study. J Neurol Neurosurg Psychiatr 71:118-122
-
(2001)
J Neurol Neurosurg Psychiatr
, vol.71
, pp. 118-122
-
-
Schlegel, U.1
Pels, H.2
Glasmacher, A.3
-
21
-
-
20444424511
-
NOA-03 trial of high-dose methotrexate in primary central nervous system lymphoma: Final report
-
DOI 10.1002/ana.20495
-
Herrlinger U, Kuker W, Uhl M et al (2005) NOA-03 trial of highdose methotrexate in primary central nervous system lymphoma: final report. Ann Neurol 57:843-847 (Pubitemid 40798622)
-
(2005)
Annals of Neurology
, vol.57
, Issue.6
, pp. 843-847
-
-
Herrlinger, U.1
Kuker, W.2
Uhl, M.3
Blaicher, H.-P.4
Karnath, H.-O.5
Kanz, L.6
Bamberg, M.7
Weller, M.8
-
22
-
-
0033986092
-
Cognitive outcomes and long-term follow-up results after enhanced chemotherapy delivery for primary central nervous system lymphoma
-
McAllister LD, Doolittle ND, Guastadisegni PE et al (2000) Cognitive outcomes and long-term follow-up results after enhanced chemotherapy delivery for primary central nervous system lymphoma. Neurosurgery 46:51-60
-
(2000)
Neurosurgery
, vol.46
, pp. 51-60
-
-
McAllister, L.D.1
Doolittle, N.D.2
Guastadisegni, P.E.3
-
23
-
-
1342309530
-
Cognitive functions in survivors of primary central nervous system lymphoma
-
Correa DD, DeAngelis LM, Shi W et al (2004) Cognitive functions in survivors of primary central nervous system lymphoma. Neurology 62:548-555 (Pubitemid 38252794)
-
(2004)
Neurology
, vol.62
, Issue.4
, pp. 548-555
-
-
Correa, D.D.1
DeAngelis, L.M.2
Shi, W.3
Thaler, H.4
Glass, A.5
Abrey, L.E.6
-
24
-
-
73349134695
-
NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide
-
Wick W, Hartmann C, Engel C et al (2009) NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide. J Clin Oncol 27:5874-5880
-
(2009)
J Clin Oncol
, vol.27
, pp. 5874-5880
-
-
Wick, W.1
Hartmann, C.2
Engel, C.3
-
25
-
-
79959978296
-
International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors
-
Lassman AB, Iwamoto FM, Cloughesy TF et al (2011) International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors. Neuro Oncol 13:649-659
-
(2011)
Neuro Oncol
, vol.13
, pp. 649-659
-
-
Lassman, A.B.1
Iwamoto, F.M.2
Cloughesy, T.F.3
-
26
-
-
33744454934
-
High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendroglioma: Long-term follow-up
-
DOI 10.1215/15228517-2005-009
-
Abrey LE, Childs BH, Paleologos N et al (2006) High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendroglioma: long-term follow-up. Neuro Oncol 8:183-188 (Pubitemid 46542663)
-
(2006)
Neuro-Oncology
, vol.8
, Issue.2
, pp. 183-188
-
-
Abrey, L.E.1
Childs, B.H.2
Paleologos, N.3
Kaminer, L.4
Rosenfeld, S.5
Salzman, D.6
Finlay, J.L.7
Gardner, S.8
Peterson, K.9
Hu, W.10
Swinnen, L.11
Bayer, R.12
Forsyth, P.13
Stewart, D.14
Smith, A.M.15
Macdonald, D.R.16
Weaver, S.17
Ramsay, D.A.18
Nimer, S.D.19
DeAngelis, L.M.20
Cairncross, J.G.21
more..
-
27
-
-
84864027175
-
A phase III intergroup study of radiotherapy versus temozolomide alone versus radiotherapy with concomitant and adjuvant temozolomide for patients with 1p/19q codeleted anaplastic glioma
-
A phase III intergroup study of radiotherapy versus temozolomide alone versus radiotherapy with concomitant and adjuvant temozolomide for patients with 1p/19q codeleted anaplastic glioma. ClinicalTrials.gov identifier: NCT00887146
-
Clinical Trials. Gov Identifier
-
-
-
28
-
-
77955817286
-
European federation of neurological societies. Guidelines on management of low-grade gliomas: Report of an EFNS-EANO task force
-
Soffietti R, Baumert BG, Bello L (2010) European federation of neurological societies. Guidelines on management of low-grade gliomas: report of an EFNS-EANO task force. Eur J Neurol 17(9):1124-1133
-
(2010)
Eur J Neurol
, vol.17
, Issue.9
, pp. 1124-1133
-
-
Soffietti, R.1
Baumert, B.G.2
Bello, L.3
-
29
-
-
0029888804
-
Low-grade oligodendroglioma responds to chemotherapy
-
Mason WP, Krol GS, DeAngelis LM (1996) Low-grade oligodendroglioma responds to chemotherapy. Neurology 46(1):203- 207 (Pubitemid 26156130)
-
(1996)
Neurology
, vol.46
, Issue.1
, pp. 203-207
-
-
Mason, W.P.1
Krol, G.S.2
DeAngelis, L.M.3
-
30
-
-
9144220435
-
Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas
-
DOI 10.1093/annonc/mdg371
-
Brada M, Viviers L, Abson C et al (2003) Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas. Ann Oncol 14(12):1715-1721 (Pubitemid 38029041)
-
(2003)
Annals of Oncology
, vol.14
, Issue.12
, pp. 1715-1721
-
-
Brada, M.1
Viviers, L.2
Abson, C.3
Hines, F.4
Britton, J.5
Ashley, S.6
Sardell, S.7
Traish, D.8
Gonsalves, A.9
Wilkins, P.10
Westbury, C.11
-
31
-
-
58949090060
-
Phase II study of protracted daily temozolomide for low-grade gliomas in adults
-
Kesari S, Schiff D, Drappatz J et al (2009) Phase II study of protracted daily temozolomide for low-grade gliomas in adults. Clin Cancer Res 15(1):330-337
-
(2009)
Clin Cancer Res
, vol.15
, Issue.1
, pp. 330-337
-
-
Kesari, S.1
Schiff, D.2
Drappatz, J.3
-
32
-
-
38049095060
-
Longitudinal cognitive follow-up in low grade gliomas
-
Correa DD, Shi W, Thaler HT et al (2008) Longitudinal cognitive follow-up in low grade gliomas. J Neurooncol 86(3):321-327
-
(2008)
J Neurooncol
, vol.86
, Issue.3
, pp. 321-327
-
-
Correa, D.D.1
Shi, W.2
Thaler, H.T.3
-
33
-
-
79957516708
-
Response assessment in neuro-oncology (a report of the RANO group): Assessment of outcome in trials of diffuse low-grade gliomas
-
van den Bent MJ, Wefel JS, Schiff D et al (2011) Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas. Lancet Oncol 12(6):583-593
-
(2011)
Lancet Oncol
, vol.12
, Issue.6
, pp. 583-593
-
-
Van Den Bent, M.J.1
Wefel, J.S.2
Schiff, D.3
-
34
-
-
84864057986
-
A phase III randomized study of radiotherapy versus temozolomide in patients with low-grade gliomas
-
A phase III randomized study of radiotherapy versus temozolomide in patients with low-grade gliomas. ClinicalTrials.gov identifier: NCT00182819
-
ClinicalTrials.gov Identifier
-
-
-
35
-
-
84864057987
-
A phase III study of radiation therapy with or without temozolomide for symptomatic or progressive low-grade gliomas
-
A phase III study of radiation therapy with or without temozolomide for symptomatic or progressive low-grade gliomas. ClinicalTrials. gov identifier: NCT00978458
-
ClinicalTrials. Gov Identifier
-
-
-
36
-
-
33745532038
-
Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: A randomized European Organisation for Research and Treatment of Cancer phase III trial
-
DOI 10.1200/JCO.2005.04.6078
-
van den Bent MJ, Carpentier AF, Brandes AA et al (2006) Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Cancer phase III trial. J Clin Oncol 24:2715-2722 (Pubitemid 46630567)
-
(2006)
Journal of Clinical Oncology
, vol.24
, Issue.18
, pp. 2715-2722
-
-
Van Den Bent, M.J.1
Carpentier, A.F.2
Brandes, A.A.3
Sanson, M.4
Taphoorn, M.J.B.5
Bernsen, H.J.J.A.6
Frenay, M.7
Tijssen, C.C.8
Grisold, W.9
Sipos, L.10
Haaxma-Reiche, H.11
Kros, J.M.12
Van Kouwenhoven, M.C.M.13
Vecht, C.J.14
Allgeier, A.15
Lacombe, D.16
Gorlia, T.17
-
37
-
-
33745575716
-
Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group trial 9402
-
DOI 10.1200/JCO.2005.04.3414
-
Cairncross G, Berkey B, Shaw E et al (2006) Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: intergroup radiation therapy oncology group trial 9402. J Clin Oncol 24:2707-2714 (Pubitemid 46630566)
-
(2006)
Journal of Clinical Oncology
, vol.24
, Issue.18
, pp. 2707-2714
-
-
Cairncross, G.1
Berkey, B.2
Shaw, E.3
Jenkins, R.4
Scheithauer, B.5
Brachman, D.6
Buckner, J.7
Fink, K.8
Souhami, L.9
Laperierre, N.10
Mehta, M.11
Curran, W.12
-
38
-
-
77952557556
-
Cognition and quality of life after chemotherapy plus radiotherapy (RT) vs. RT for pure and mixed anaplastic oligodendrogliomas: Radiation therapy oncology group trial 9402
-
Wang M, Cairncross G, Shaw E et al (2010) Cognition and quality of life after chemotherapy plus radiotherapy (RT) vs. RT for pure and mixed anaplastic oligodendrogliomas: radiation therapy oncology group trial 9402. Int J Radiat Oncol Biol Phys 77:662-669
-
(2010)
Int J Radiat Oncol Biol Phys
, vol.77
, pp. 662-669
-
-
Wang, M.1
Cairncross, G.2
Shaw, E.3
-
39
-
-
37649008911
-
Healthrelated quality of life in patients treated for anaplastic oligodendroglioma with adjuvant chemotherapy: Results of a European Organisation for research and treatment of cancer randomized clinical trial
-
Taphoorn MJ, van den Bent MJ, Mauer ME et al (2007) Healthrelated quality of life in patients treated for anaplastic oligodendroglioma with adjuvant chemotherapy: results of a European Organisation for research and treatment of cancer randomized clinical trial. J Clin Oncol 25:5723-5730
-
(2007)
J Clin Oncol
, vol.25
, pp. 5723-5730
-
-
Taphoorn, M.J.1
Van Den Bent, M.J.2
Mauer, M.E.3
-
40
-
-
33644910465
-
Surviving glioblastoma for more than 5 years: The patient's perspective
-
DOI 10.1212/01.wnl.0000194221.89948.a0, PII 0000611420060124000021
-
Steinbach JP, Blaicher HP, Herrlinger U et al (2006) Surviving glioblastoma for more than 5 years: the patient's perspective. Neurology 66:239-242 (Pubitemid 43970162)
-
(2006)
Neurology
, vol.66
, Issue.2
, pp. 239-242
-
-
Steinbach, J.P.1
Blaicher, H.-P.2
Herrlinger, U.3
Wick, W.4
Nangele, T.5
Meyermann, R.6
Tatagiba, M.7
Bamberg, M.8
Dichgans, J.9
Karnath, H.-O.10
Weller, M.11
-
42
-
-
20044366163
-
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
-
DOI 10.1056/NEJMoa043330
-
Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987-996 (Pubitemid 40349501)
-
(2005)
New England Journal of Medicine
, vol.352
, Issue.10
, pp. 987-996
-
-
Stupp, R.1
Mason, W.P.2
Van Den Bent, M.J.3
Weller, M.4
Fisher, B.5
Taphoorn, M.J.B.6
Belanger, K.7
Brandes, A.A.8
Marosi, C.9
Bogdahn, U.10
Curschmann, J.11
Janzer, R.C.12
Ludwin, S.K.13
Gorlia, T.14
Allgeier, A.15
Lacombe, D.16
Cairncross, J.G.17
Eisenhauer, E.18
Mirimanoff, R.O.19
-
43
-
-
65349121788
-
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
-
Stupp R, Hegi ME, Mason WP et al (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10:459-466
-
(2009)
Lancet Oncol
, vol.10
, pp. 459-466
-
-
Stupp, R.1
Hegi, M.E.2
Mason, W.P.3
-
44
-
-
77949264925
-
Cognitive functioning in glioblastoma patients during radiotherapy and temozolomide treatment: Initial findings
-
Hilverda K, Bosma I, Heimans JJ et al (2010) Cognitive functioning in glioblastoma patients during radiotherapy and temozolomide treatment: initial findings. J Neurooncol 97:89-94
-
(2010)
J Neurooncol
, vol.97
, pp. 89-94
-
-
Hilverda, K.1
Bosma, I.2
Heimans, J.J.3
-
45
-
-
79955748407
-
Aggressive treatment is appropriate for glioblastoma multiforme patients 70 years old or older: A retrospective review of 206 cases
-
Scott JG, Suh JH, Elson P et al (2011) Aggressive treatment is appropriate for glioblastoma multiforme patients 70 years old or older: a retrospective review of 206 cases. Neuro Oncol 13:428-436
-
(2011)
Neuro Oncol
, vol.13
, pp. 428-436
-
-
Scott, J.G.1
Suh, J.H.2
Elson, P.3
-
46
-
-
68149182696
-
Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma: Correlation with MGMT promoter methylation status
-
Brandes AA, Franceschi E, Tosoni A et al (2009) Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma: correlation with MGMT promoter methylation status. Cancer 115:3512-3518
-
(2009)
Cancer
, vol.115
, pp. 3512-3518
-
-
Brandes, A.A.1
Franceschi, E.2
Tosoni, A.3
-
47
-
-
42349090207
-
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma in elderly patients
-
Minniti G, De Sanctis V, Muni R et al (2008) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma in elderly patients. J Neurooncol 88:97-103
-
(2008)
J Neurooncol
, vol.88
, pp. 97-103
-
-
Minniti, G.1
De Sanctis, V.2
Muni, R.3
-
48
-
-
46949100273
-
Toxicity from chemoradiotherapy in older patients with glioblastoma multiforme
-
Sijben AE, McIntyre JB, Roldán GB et al (2008) Toxicity from chemoradiotherapy in older patients with glioblastoma multiforme. J Neurooncol 89:97-103
-
(2008)
J Neurooncol
, vol.89
, pp. 97-103
-
-
Sijben, A.E.1
McIntyre, J.B.2
Roldán, G.B.3
-
49
-
-
84864047031
-
A randomized phase III study of temozolomide and short-course radiation versus short-course radiation alone in the treatment of newly diagnosed glioblastoma multiforme in elderly patients
-
A randomized phase III study of temozolomide and short-course radiation versus short-course radiation alone in the treatment of newly diagnosed glioblastoma multiforme in elderly patients. Clinicaltrials.gov identifier: NCT00482677
-
Clinicaltrials.gov Identifier
-
-
-
50
-
-
80051659072
-
Temozolomide in elderly patients with newly diagnosed glioblastoma and poor performance status: An ANOCEF phase II trial
-
Gállego Pérez-Larraya J, Ducray F, Chinot O et al (2011) Temozolomide in elderly patients with newly diagnosed glioblastoma and poor performance status: an ANOCEF phase II trial. J Clin Oncol 29(22):3050-3055
-
(2011)
J Clin Oncol
, vol.29
, Issue.22
, pp. 3050-3055
-
-
Gállego Pérez-Larraya, J.1
Ducray, F.2
Chinot, O.3
-
51
-
-
79959947030
-
Neurocognitive function in patients with recurrent glioblastoma treated with bevacizumab
-
Wefel JS, Cloughesy T, Zazzali JL et al (2011) Neurocognitive function in patients with recurrent glioblastoma treated with bevacizumab. Neuro Oncol 13:660-668
-
(2011)
Neuro Oncol
, vol.13
, pp. 660-668
-
-
Wefel, J.S.1
Cloughesy, T.2
Zazzali, J.L.3
|